Boston Common Stock vs Capital Surpluse Analysis

BSX Stock

USD 73.17 0.09 0.12%

Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Common Stock and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Common Stock vs Capital Surpluse

Common Stock vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Common Stock account and Capital Surpluse. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Boston Scientific's Common Stock and Capital Surpluse is 0.47. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Common Stock and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Boston Scientific Corp are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Common Stock i.e., Boston Scientific's Common Stock and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Common Stock

Capital Surpluse

Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 679.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	8.1B	8.7B	9.9B	10.4B
Total Revenue	11.9B	12.7B	14.2B	15.0B

Gross Profit Total Revenue

Boston Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.96	0.82	0.73	0.97	0.99	0.94	0.5	0.89	0.62	1.0	0.67	0.62	0.94	0.63	0.74	0.93	0.13	0.63	0.77	0.77	0.83	0.1	0.59	0.71	0.78
Short Long Term Debt Total	0.96		0.86	0.8	0.91	0.93	0.99	0.46	0.86	0.61	0.96	0.77	0.61	0.91	0.58	0.76	0.87	0.14	0.6	0.82	0.67	0.85	0.23	0.59	0.68	0.85
Other Current Liab	0.82	0.86		0.91	0.74	0.82	0.86	0.28	0.85	0.48	0.81	0.84	0.48	0.86	0.54	0.56	0.78	0.39	0.55	0.72	0.63	0.73	0.34	0.5	0.65	0.86
Total Current Liabilities	0.73	0.8	0.91		0.64	0.73	0.83	0.19	0.76	0.27	0.72	0.93	0.27	0.84	0.52	0.43	0.73	0.58	0.5	0.67	0.58	0.63	0.67	0.53	0.61	0.89
Total Stockholder Equity	0.97	0.91	0.74	0.64		0.97	0.87	0.65	0.9	0.64	0.97	0.55	0.64	0.88	0.5	0.64	0.94	0.03	0.5	0.65	0.8	0.78	0.01	0.43	0.58	0.77
Property Plant And Equipment Net	0.99	0.93	0.82	0.73	0.97		0.91	0.5	0.93	0.58	0.98	0.66	0.58	0.95	0.59	0.67	0.97	0.11	0.58	0.71	0.84	0.79	0.08	0.53	0.69	0.78
Net Debt	0.94	0.99	0.86	0.83	0.87	0.91		0.41	0.83	0.46	0.94	0.82	0.47	0.93	0.59	0.73	0.87	0.19	0.6	0.82	0.67	0.79	0.32	0.64	0.68	0.84
Retained Earnings	0.5	0.46	0.28	0.19	0.65	0.5	0.41		0.59	0.45	0.5	0.04	0.45	0.3	-0.29	0.05	0.55	-0.41	-0.23	0.05	0.56	0.3	-0.13	-0.31	-0.18	0.57
Accounts Payable	0.89	0.86	0.85	0.76	0.9	0.93	0.83	0.59		0.55	0.89	0.65	0.56	0.89	0.38	0.49	0.94	0.08	0.41	0.58	0.81	0.7	0.12	0.3	0.53	0.85
Cash	0.62	0.61	0.48	0.27	0.64	0.58	0.46	0.45	0.55		0.59	0.18	1.0	0.39	0.3	0.59	0.45	-0.13	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Non Current Assets Total	1.0	0.96	0.81	0.72	0.97	0.98	0.94	0.5	0.89	0.59		0.67	0.59	0.94	0.63	0.74	0.93	0.13	0.62	0.77	0.76	0.81	0.11	0.6	0.7	0.77
Non Currrent Assets Other	0.67	0.77	0.84	0.93	0.55	0.66	0.82	0.04	0.65	0.18	0.67		0.18	0.81	0.58	0.49	0.66	0.58	0.57	0.7	0.46	0.6	0.64	0.61	0.66	0.77
Cash And Short Term Investments	0.62	0.61	0.48	0.27	0.64	0.58	0.47	0.45	0.56	1.0	0.59	0.18		0.39	0.3	0.59	0.45	-0.13	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Net Receivables	0.94	0.91	0.86	0.84	0.88	0.95	0.93	0.3	0.89	0.39	0.94	0.81	0.39		0.69	0.67	0.94	0.29	0.65	0.76	0.78	0.73	0.27	0.67	0.77	0.77
Common Stock Shares Outstanding	0.63	0.58	0.54	0.52	0.5	0.59	0.59	-0.29	0.38	0.3	0.63	0.58	0.3	0.69		0.82	0.46	0.52	0.96	0.84	0.26	0.69	0.17	0.95	0.95	0.28
Non Current Liabilities Total	0.74	0.76	0.56	0.43	0.64	0.67	0.73	0.05	0.49	0.59	0.74	0.49	0.59	0.67	0.82		0.53	0.06	0.89	0.94	0.27	0.88	-0.04	0.83	0.86	0.38
Inventory	0.93	0.87	0.78	0.73	0.94	0.97	0.87	0.55	0.94	0.45	0.93	0.66	0.45	0.94	0.46	0.53		0.07	0.45	0.59	0.92	0.67	0.12	0.42	0.6	0.77
Other Current Assets	0.13	0.14	0.39	0.58	0.03	0.11	0.19	-0.41	0.08	-0.13	0.13	0.58	-0.13	0.29	0.52	0.06	0.07		0.42	0.28	-0.01	0.16	0.69	0.45	0.41	0.3
Other Stockholder Equity	0.63	0.6	0.55	0.5	0.5	0.58	0.6	-0.23	0.41	0.43	0.62	0.57	0.43	0.65	0.96	0.89	0.45	0.42		0.91	0.21	0.81	0.13	0.9	0.96	0.32
Total Liab	0.77	0.82	0.72	0.67	0.65	0.71	0.82	0.05	0.58	0.54	0.77	0.7	0.54	0.76	0.84	0.94	0.59	0.28	0.91		0.32	0.92	0.25	0.84	0.89	0.59
Property Plant And Equipment Gross	0.77	0.67	0.63	0.58	0.8	0.84	0.67	0.56	0.81	0.29	0.76	0.46	0.29	0.78	0.26	0.27	0.92	-0.01	0.21	0.32		0.44	0.05	0.2	0.41	0.63
Total Current Assets	0.83	0.85	0.73	0.63	0.78	0.79	0.79	0.3	0.7	0.78	0.81	0.6	0.78	0.73	0.69	0.88	0.67	0.16	0.81	0.92	0.44		0.1	0.62	0.81	0.68
Short Term Debt	0.1	0.23	0.34	0.67	0.01	0.08	0.32	-0.13	0.12	-0.26	0.11	0.64	-0.26	0.27	0.17	-0.04	0.12	0.69	0.13	0.25	0.05	0.1		0.28	0.17	0.51
Intangible Assets	0.59	0.59	0.5	0.53	0.43	0.53	0.64	-0.31	0.3	0.17	0.6	0.61	0.17	0.67	0.95	0.83	0.42	0.45	0.9	0.84	0.2	0.62	0.28		0.88	0.27
Common Stock Total Equity	0.71	0.68	0.65	0.61	0.58	0.69	0.68	-0.18	0.53	0.41	0.7	0.66	0.41	0.77	0.95	0.86	0.6	0.41	0.96	0.89	0.41	0.81	0.17	0.88		0.4
Short Term Investments	0.78	0.85	0.86	0.89	0.77	0.78	0.84	0.57	0.85	0.48	0.77	0.77	0.48	0.77	0.28	0.38	0.77	0.3	0.32	0.59	0.63	0.68	0.51	0.27	0.4

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.6B	30.8B	32.2B	32.5B	35.1B	36.9B
Short Long Term Debt Total	10.3B	9.5B	9.5B	9.3B	9.5B	10.0B
Other Current Liab	2.8B	3.0B	3.0B	2.7B	3.2B	3.4B
Total Current Liabilities	4.9B	3.7B	4.3B	3.8B	4.9B	5.2B
Total Stockholder Equity	13.9B	15.3B	16.6B	17.6B	19.3B	20.2B
Property Plant And Equipment Net	2.4B	2.5B	2.7B	2.8B	3.3B	3.5B
Net Debt	10.1B	7.8B	7.5B	8.4B	8.6B	9.1B
Retained Earnings	(2.3B)	(2.4B)	(1.4B)	(750M)	819M	860.0M
Accounts Payable	542M	513M	794M	862M	942M	989.1M
Non Current Assets Total	25.9B	24.1B	25.9B	26.7B	28.6B	30.1B
Non Currrent Assets Other	735M	545M	563M	707M	679M	713.0M
Net Receivables	1.9B	1.5B	1.8B	2.0B	2.2B	2.3B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.4B	1.5B	1.2B
Liabilities And Stockholders Equity	30.6B	30.8B	32.2B	32.5B	34.9B	36.6B
Non Current Liabilities Total	11.8B	11.8B	11.3B	11.1B	10.7B	6.2B
Inventory	1.6B	1.4B	1.6B	1.9B	2.5B	2.6B
Other Current Assets	324M	410M	385M	350M	333M	426.3M
Other Stockholder Equity	15.8B	17.5B	17.7B	18.0B	18.4B	10.0B
Total Liab	16.7B	15.5B	15.6B	14.9B	15.6B	8.6B
Property Plant And Equipment Gross	2.4B	2.5B	2.3B	2.4B	6.8B	7.1B
Total Current Assets	4.7B	6.7B	6.3B	5.8B	6.5B	3.3B
Accumulated Other Comprehensive Income	270M	207M	263M	269M	49M	51.5M
Short Term Debt	1.4B	13M	261M	20M	531M	417.5M
Intangible Assets	7.9B	5.9B	6.1B	5.9B	6.0B	4.9B
Other Liab	3.0B	2.2B	2.1B	1.8B	2.1B	1.9B
Other Assets	(2M)	4.6B	3M	2M	(1M)	950K
Long Term Debt	8.6B	9.1B	8.8B	8.9B	8.6B	5.6B
Good Will	10.2B	10.0B	12.0B	12.9B	14.4B	8.6B
Property Plant Equipment	2.1B	2.1B	2.3B	2.8B	3.3B	1.7B
Current Deferred Revenue	144M	138M	208M	220M	266M	333.1M
Net Tangible Assets	(4.2B)	9.4B	(1.7B)	11.7B	13.4B	14.1B
Retained Earnings Total Equity	(2.3B)	(2.4B)	(1.4B)	(750M)	(862.5M)	(905.6M)
Long Term Debt Total	8.6B	9.1B	8.8B	8.9B	10.3B	6.6B

Boston Scientific Investors Sentiment

The influence of Boston Scientific's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Boston. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Boston Scientific's public news can be used to forecast risks associated with an investment in Boston. The trend in average sentiment can be used to explain how an investor holding Boston can time the market purely based on public headlines and social activities around Boston Scientific Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Boston Scientific's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Boston Scientific's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Boston Scientific's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Boston Scientific.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Boston Scientific in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Boston Scientific's short interest history, or implied volatility extrapolated from Boston Scientific options trading.

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving against Boston Stock

0.72	GH	Guardant Health Financial Report 14th of May 2024	Pair Corr
0.54	DNA	Ginkgo Bioworks Holdings Financial Report 8th of May 2024	Pair Corr
0.43	PFE	Pfizer Inc Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.

The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.856

Earnings Share

1.07

Revenue Per Share

9.8

Quarterly Revenue Growth

0.149

Return On Assets

0.0447

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Common Stock vs Capital Surpluse Analysis

Common Stock vs Capital Surpluse

Common Stock vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Common Stock

Capital Surpluse

Boston Scientific fundamental ratios Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific fundamental ratios Accounts

Boston Scientific Investors Sentiment

Pair Trading with Boston Scientific

Moving against Boston Stock

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.97	Total Assets

Other Current Assets	- 0.41	Retained Earnings
Intangible Assets	- 0.31	Retained Earnings
Common Stock Shares Outstanding	- 0.29	Retained Earnings
Short Term Debt	- 0.26	Cash And Short Term Investments
Short Term Debt	- 0.26	Cash
Other Stockholder Equity	- 0.23	Retained Earnings